Last updated: April 30, 2026
Fluconazole in Sodium Chloride 0.9% (typically an IV admixture presented as a ready-to-infuse sterile solution in a plastic container, depending on jurisdiction and label) is supplied by branded manufacturers and by contract manufacturing networks that produce sterile IV products for distributors and wholesalers. Public-facing “supplier lists” vary by country, strength (mg/mL), container type (e.g., PVC-free bags, pharmacy bulk packs, single-dose vs multi-dose), and regulatory labeling (brand vs generic).
What supplier types provide this product?
- Originator/brand manufacturers of fluconazole IV products in saline-compatible bags (labelled “fluconazole injection” in sodium chloride 0.9% where applicable by market).
- Generic sterile injectables manufacturers producing fluconazole IV in 0.9% saline, packaged in plastic infusion containers.
- Contract manufacturing organizations (CMOs) supplying sterile IV solutions to label holders (often under private label arrangements for hospital or distributor brands).
Which companies have direct market presence for fluconazole IV injection in 0.9% sodium chloride (plastic container formats)?
The suppliers most commonly encountered in pharma distribution channels for fluconazole IV injection (including 0.9% sodium chloride compatible presentations) include the following manufacturer groups that have established sterile injectables footprints and recurring presence in fluconazole IV supply chains:
| Supplier group (manufacturer) |
Supply role in the fluconazole IV saline segment |
Typical distribution pattern |
| Pfizer |
Brand-origin sterile antifungal IV lines in multiple markets |
Direct + distributor channels |
| Hospira (legacy) / Pfizer Injectables |
Sterile injectables producer for IV antifungals in many jurisdictions |
Distributor and hospital networks |
| Sandoz (Novartis) |
Generic sterile injectables, including antifungals in IV |
National wholesaler supply |
| Teva |
Generic sterile injectables including IV antifungals in several markets |
Private label and brand generics via wholesalers |
| Mylan (Viatris legacy) |
Generic sterile injectables supply for IV antifungals |
Generic tender supply |
| Sagent Pharmaceuticals (U.S. brand generics ecosystem) |
Private label/generic sterile injectables for infusion products |
Distributor and hospital contracts |
| Dr. Reddy’s Laboratories |
Generic injectables portfolio including antifungals in multiple markets |
Tender and wholesaler networks |
| Accord Healthcare |
Generic sterile injectables in IV format |
Hospital and distributor contracts |
| Fresenius Kabi |
Sterile products supplier with strong IV portfolio |
Hospital system supply routes |
| B. Braun |
IV/infusion portfolio and sourcing networks for sterile solutions |
Hospital procurement channels |
How to map “plastic container” to real-world packaging formats
For this product category, “plastic container” is usually one of these packaging regimes:
- IV infusion bags (commonly PVC-free / flexible plastic, depending on local product registration)
- Single-dose or multi-dose pharmacy-use containers supplied to hospitals/pharmacies
- Bulk packaging (where allowed) that is relabeled/segmented by distributors in some systems
Market listings often describe the container type indirectly via the dosage form labeling (e.g., “injection,” “solution for infusion,” “sterile,” “in sodium chloride 0.9%”) while the physical bag material details appear in local product monographs and packaging inserts.
Where to verify the actual named manufacturer per container presentation
In practice, the cleanest way to identify the actual supplier for a specific fluconazole in sodium chloride 0.9% in plastic container SKU is to match:
- Strength (commonly specified as mg/xx mL or mg/xx mL)
- Dosage form wording (“fluconazole injection”, “solution for infusion”, or “in 0.9% sodium chloride”)
- Container size (e.g., x mL)
- Label holder and manufacturer name on the finished product carton/bag
- Regulatory listing (FDA/EMA-style database per jurisdiction, or national drug registers)
This is because the same active ingredient and the same solvent can exist across multiple manufacturers, and tendered hospital brands can be produced by different CMOs.
Supplier landscape by region (what dominates procurement lists)
U.S. procurement pattern
In the U.S., fluconazole IV products are typically listed and purchased through wholesalers with SKU-level manufacturer attribution on product labels (brand and AB-rated generics). The named manufacturer can differ by:
- strength and container size
- whether it is a hospital brand or a national generic
- supply disruptions that trigger alternate labeling sources
EU/UK procurement pattern
In Europe, tender and hospital systems frequently source through national distributors that carry multiple generic holders. The manufacturer for the sterile bulk can shift by:
- marketing authorization holder
- batch releases and alternative manufacturer arrangements
Key practical implications for choosing suppliers
- Supplier identity must be SKU-specific: “fluconazole in sodium chloride 0.9%” does not uniquely identify a single manufacturer across all strengths and bag sizes.
- Tender listings often reflect the label holder, not the CMO: procurement may show the label brand while production can occur across multiple manufacturing sites.
- Container specifications can restrict eligible suppliers: pharmacy and hospital groups often require PVC-free or specific administration setups; only certain products meet those constraints.
Key Takeaways
- The supply of fluconazole IV in sodium chloride 0.9% in plastic containers is delivered by a mix of brand manufacturers, generic sterile injectables makers, and CMOs supplying label holders.
- Commonly encountered supplier groups with sterile injectables capability and frequent market presence include Pfizer, Sandoz, Teva, Viatris (Mylan legacy), Dr. Reddy’s, Accord, Fresenius Kabi, and B. Braun (varies by jurisdiction and SKU).
- The actual supplier for your exact plastic container presentation must be matched at SKU level using the labeled manufacturer on the finished product and the local regulatory product listing.
FAQs
1) Is there a single global supplier for fluconazole in sodium chloride 0.9% in plastic containers?
No. Availability is typically split across brand and multiple generic manufacturers, with SKU and region-specific label holders and manufacturing sites.
2) Can the label holder differ from the manufacturing site?
Yes. Finished-product label holders commonly use contract manufacturing; the label carton lists the manufacturer of record, but production arrangements can vary.
3) Do packaging details affect supplier eligibility?
Yes. Hospitals often require specific bag materials (for example PVC-free) and administration compatibility, which can limit which suppliers qualify in procurement.
4) Why do wholesalers list different manufacturers for the same description?
Batch supply shifts, regulatory alternatives, and tender-driven sourcing can result in different AB-equivalent products arriving with different manufacturer names.
5) What is the fastest way to identify the actual supplier for a given SKU?
Use the SKU-specific carton/bag labeling (manufacturer of record) and match it to the local regulatory listing for the exact strength, container size, and dosage form wording.
References
[1] FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] EMA. (n.d.). European Medicines Agency: Medicines. European Medicines Agency. https://www.ema.europa.eu/en/medicines
[3] NHS. (n.d.). Fluconazole: Patient information and prescribing guidance (where available by UK listings). National Health Service. https://www.nhs.uk/
